A randomized, open-label clinical trial on the efficacy of blonanserin and olanzapine in patients with schizophrenia and dopamine supersensitivity psychosis
Phase 4
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000017047
- Lead Sponsor
- Chiba University Hospital Clinical Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 61
Inclusion Criteria
Not provided
Exclusion Criteria
1)[Criteria for DSP] First episode schizophrenia 2)[Criteria for DSP] Unstable and continuous severe psychotic symptoms under antipsychotic treatment for more than 3 months 3))[Criteria for DSP] Deficit syndrome 4)Contraindication to blonanserin/olanzapine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method